AzTrials
AzTrials

Primary PreventionNFNCT04162626

New Families- Innovation and Development of the Child Health Services in Oslo

A study testing Supportive home visits to new families and Treatment as usual in people with Primary Prevention, run by VID Specialized University at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The New Families (NF) program will improve quality of existing services, secure personalised service and early intervention in Child Health Service (CHS) in Oslo. The study will measure the effects of a primary prevention family-centered healthcare intervention in Norwegian CHS. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Primary Prevention
What is being tested?
Supportive home visits to new families and Treatment as usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
428 participants
Where
1 siteNorway
Study dates
8 Oct 2018to 1 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • First time parents living in the chosen districts

Who cannot join

  • All other parents

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • VID Specialized University

    Oslo, NO-0319

Other trials in Norway

About this study

The New Families (NF) program will improve quality of existing services, secure personalised service and early intervention in Child Health Service (CHS) in Oslo. The study will measure the effects of a primary prevention family-centered healthcare intervention in Norwegian CHS.

Read the detailed description

The New Families (NF) program will improve quality of existing services, secure personalised service and early intervention in Child Health Service (CHS) in Oslo. The study will: 1) Measure the effects of a primary prevention family-centered healthcare intervention in Norwegian CHS, 2) Create case studies from CHS praxis advancing Public Health Nurse (PHN) training and education in Oslo and Norway, 3) Establish a model for how to include users in service development in CHS, 4) Enhance the knowledge base of the PHN practice in CHS Anticipated results: The project will bolster the knowledge base for education and professional practices within the service by strengthen the existing research within the field. The anticipated results of the project are that the intervention will increase maternal and parental self-efficacy, reduce the risk of postpartum depression among first-time mothers, reduce parental stress, increase social support, improve maternal attachment, improve generic health status, improve partner relationship and improve child development compared with usual care. The intervention research in this project can be a future model for service improvement in the CHS.

Being tested
Supportive home visits to new families, Treatment as usual
Keywords
public health nurse, intervention, home visit

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Supportive home visits to new familiesOther

    The new families are offered home visits by a public health nurse from 28 weeks in pregnancy until the child is two years old. The number of home visits depends on the families needs and wishes. They also get the usual follow up from the Child health center.

  • Treatment as usualOther

    Follow up at the Child health center according to national regulations

Study groups in NCT04162626
Study groupRoleWhat they receive
InterventionExperimentalSupportive home visits by public health nurses to new parents from 28 weeks in pregnancy until the child is two years.
Receives: Other: Supportive home visits to new families
ControlOtherFollow up as usual at the Child health center
Receives: Other: Treatment as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression in mothers in pregnancy

    Edinburgh postnatal depression scale (EPDS). 10 items. Score 0-30. Score 12 or above indicate postpartum depression.

    Measured: 28 weeks pregnancy

  2. Depression in fathers when partner is pregnant

    Edinburgh postnatal depression scale (EPDS). 10 items. Score 0-30. Score 12 or above indicate postpartum depression.

    Measured: 28 weeks pregnancy

  3. Depression in mothers three months postpartum

    Edinburgh postnatal depression scale (EPDS). 10 items. Score 0-30. Score 12 or above indicate postpartum depression.

    Measured: 3 months postpartum

  4. Depression in fathers three months postpartum

    Edinburgh postnatal depression scale (EPDS). 10 items. Score 0-30. Score 12 or above indicate postpartum depression.

    Measured: 3 months postpartum

  5. Sense of Coherence in mothers in pregnancy

    Sense of Coherence Scale (SOC 13). 26 items. Score 13-90. Higher score is positive, score under 66 is low.

    Measured: 28 weeks pregnancy

  6. Sense of Coherence in fathers in pregnancy

    Sense of Coherence Scale (SOC 13). 26 items. Score 13-90. Higher score is positive, score under 66 is low.

    Measured: 28 weeks pregnancy

  7. Sense of Coherence in mothers three months postpartum

    Sense of Coherence Scale (SOC 13). 26 items. Score 13-90. Higher score is positive, score under 66 is low.

    Measured: 3 months postpartum

  8. Sense of Coherence in fathers three months postpartum

    Sense of Coherence Scale (SOC 13). 26 items. Score 13-90. Higher score is positive, score under 66 is low.

    Measured: 3 months postpartum

  9. Self-Efficacy in mothers 6 weeks postpartum

    Perceived Maternal Parenting Self-Efficacy (PMP S-E) 20 items. score 22-88. A higher score indicates a higher level of maternal self-efficacy

    Measured: 6 weeks postpartum

  10. Self-Efficacy in fathers 6 weeks postpartum

    Perceived Maternal Parenting Self-Efficacy (PMP S-E) 20 items. score 22-88. A higher score indicates a higher level of maternal self-efficacy

    Measured: 6 weeks postpartum

  11. Self-Efficacy in mothers 3 months postpartum

    Perceived Maternal Parenting Self-Efficacy (PMP S-E) 20 items. score 22-88. A higher score indicates a higher level of maternal self-efficacy

    Measured: 3 months postpartum

  12. Self-Efficacy in fathers 3 months postpartum

    Perceived Maternal Parenting Self-Efficacy (PMP S-E) 20 items. score 22-88. A higher score indicates a higher level of maternal self-efficacy

    Measured: 3 months postpartum

  13. Parental Stress in fathers 3 months postpartum

    Parental Stress Scale (PSS) is formatted in the form of an 18-item self-report scale. Items represent positive (e.g. emotional benefits, personal development) and negative (demands on resources, restrictions) themes of parenthood. A higher score indicates a higher level of parental stress.

    Measured: 3 months postpartum

  14. Parental Stress in mothers 3 months postpartum

    Parental Stress Scale (PSS) is formatted in the form of an 18-item self-report scale. Items represent positive (e.g. emotional benefits, personal development) and negative (demands on resources, restrictions) themes of parenthood. A higher score indicates a higher level of parental stress.

    Measured: 3 months postpartum

  15. Quality of Life in women and men during pregnancy and postpartum

    To explore first-time parents' QoL during pregnancy and first-time mothers QoL postpartum, and to evaluate the difference in QoL between mothers in the intervention and control districts. Instrument: WHOQOL-BREF, 26-item. Score 4-20, higher scores indicate higher QoL.

    Measured: Pregnancy week 28, 3 months postpartum, 12 months postpartum.

Secondary outcomes (1)
  1. What are the barriers and facilitators to implementation of the PHN intervention?

    This research question will be explored by addressing the process of implementation.

    Data will be collected through a short survey and semi-structured interviews with PHNs and users (first-time mothers/fathers).

    An interview guide will be developed

    Measured: The interviews will take place about 12 months postpartum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2019
  2. Study start8 Oct 2018
  3. Primary completion1 Jun 2021
  4. Study completion1 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
428 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04162626
Sponsor's protocol ID
2018/1378
Acronym
NF
Status last verified
Jan 2025
First submitted
11 Nov 2019
Last updated
13 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There will be four doctoral students (PhD) in the project

Publications

  • Saether KM, Hagen MC, Holmberg Fagerlund B, Glavin K, Brekke M, Solberg B, Oygarden AU, Joranson N. The Impact of a Home Visiting Program on First-Time Parents' Parental Self-Efficacy in Norway and Associations between Parental Self-Efficacy, Depressive Symptoms and Perception of Sleep. Public Health Nurs. 2026 May-Jun;43(3):653-666. doi: 10.1111/phn.70098. Epub 2026 Feb 28.

    PubMed 41762203
  • Brekke M, Smastuen MC, Glavin K, Amro A, Solberg B, Oygarden AU, Saether KM, Haugland T. The impact of New Families home visiting program on first-time mothers' quality of life and its association with social support: a non-randomized controlled study. BMC Public Health. 2023 Dec 8;23(1):2457. doi: 10.1186/s12889-023-17285-0.

    PubMed 38066502

Questions about this trial

What is this clinical trial studying?

A study testing Supportive home visits to new families and Treatment as usual in people with Primary Prevention, run by VID Specialized University at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression in mothers in pregnancy (time frame: 28 weeks pregnancy). The study lists 15 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04162626, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in